Skinvisible(R) Launches New Invisicare(R) Website; Dermatology Licensing Opportunities With New Topical Delivery System Identified
In addition to the launch of the new website www.invisicare.com, Skinvisible is pleased to announce the addition of two new staff to its scientific team; Ms. Teresa Petraia and Dr. Justin Zhang Ph.D. Teresa is a specialist in skin care R&D as well as manufacturing and brings over 20 years of development experience to the Company having worked for Beiersdorf and Procter & Gamble. Dr. Zhang holds a Ph.D. in Chemistry with a MSc. in polymers and prior to joining Skinvisible was a research scientist with the Department of Chemistry at the University of California in Riverside.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals is a research-and-development company that has formulated and patented innovative polymer delivery system technology and compositions for topical skin applications. Skinvisible's primary marketing and sales objective is to license its technology and sell its trademarked polymer delivery vehicle Invisicare to established dermatological, cosmetic, skincare and pharmaceutical manufacturers.
LAS VEGAS, Oct. 24 /PRNewswire-FirstCall/ -- Skinvisible, Inc.(OTC Bulletin Board: SKVI) announced today that it has launched a new websitewww.invisicare.com, dedicated solely to the Company's dermatology product lineand licensing opportunities for the pharmaceutical and cosmetic industry. Thecorporate website, www.skinvisible.com, will remain, with its emphasis oncorporate issues and investor relations.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO
http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO )
Invisicare is an innovative, patented delivery system that is designed to enhance product performance. It has the proven ability to bond active ingredients to the skin for up to 4 hours and longer, while at the same time allowing the skin to breathe and perspire normally. This result is a protective bond, resistant to wash-off, delivering targeted levels of therapeutic or cosmetic skincare agents directly to the skin.
"We are very excited to launch this website that explains our patented polymer delivery system; Invisicare in detail. The website will also showcase to pharmaceutical companies skincare related licensing opportunities, and allow them to understand the depth and breadth of our product offering. In addition to detailing our product lines available in acne, atopic dermatitis, fungal, sun care and antimicrobial hand sanitizers, it allows people to sign up to receive any announcements of new product developments, plus any new clinical trial results," says Mr. Terry Howlett, Skinvisible's President and CEO.
In addition to the launch of the new website www.invisicare.com, Skinvisible is pleased to announce the addition of two new staff to its scientific team; Ms. Teresa Petraia and Dr. Justin Zhang Ph.D. Teresa is a specialist in skin care R&D as well as manufacturing and brings over 20 years of development experience to the Company having worked for Beiersdorf and Procter & Gamble. Dr. Zhang holds a Ph.D. in Chemistry with a MSc. in polymers and prior to joining Skinvisible was a research scientist with the Department of Chemistry at the University of California in Riverside.
"We are pleased to expand our research and development team with the addition of Teresa and Justin. Their expertise will be utilized to assist pharmaceutical companies in recognizing the value-added effect of Invisicare when combined with their own proprietary actives," says Dr. James Roszell, V.P. of Research & Development.
About Skinvisible Pharmaceuticals, Inc.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals is a research-and-development company that has formulated and patented innovative polymer delivery system technology and compositions for topical skin applications. Skinvisible's primary marketing and sales objective is to license its technology and sell its trademarked polymer delivery vehicle Invisicare to established dermatological, cosmetic, skincare and pharmaceutical manufacturers. For more information, visit: www.skinvisible.com.
Forward-Looking Statements
This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10QSB for the quarter ending June 30, 2006.
Jomashop coupon code
Skinit coupon code
Dermstore coupon code
Zagg coupon code
Mymms coupon code
Supermediastore coupon code